New SEC Filings Reveal Major Risks In Cannabis ETFs Following Recent Volatility — But There's Still Room for Optimism
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 22 2024
0mins
Source: Benzinga
Current Challenges for Cannabis ETFs: The AdvisorShares Pure US Cannabis ETF (MSOS) and its leveraged counterpart (MSOX) are facing significant challenges due to regulatory uncertainty, underperforming stocks, and structural issues, leading to mixed performance in the volatile cannabis market.
Potential for Future Growth: Despite current difficulties, potential regulatory reforms such as cannabis rescheduling and supportive political momentum could revitalize the cannabis sector and improve conditions for ETFs like MSOS and MSOX, attracting institutional investment and enhancing profitability.
Analyst Views on MSOS
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 4.520
Low
Averages
High
Current: 4.520
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
